Sale!
GIVLAARI Drug Profile, 2024

GIVLAARI Drug Profile, 2024

Original price was: $800.00.Current price is: $399.00.

GIVLAARI (givosiran sodium) drug patents, SPCs, clinical trials, suppliers

SKU: GIVLAARI Category:
Originally published at https://www.chemintel360.com/. Get our excipient business reports at https://chemintel360.com/product-category/excipients/, and our drug patent reports at https://chemintel360.com/product-category/drug-patent-reports/

GIVLAARI Drug Profile, 2024 is part of DrugPatentWatch’s deep library of business intelligence on biopharmaceutical drugs.

This definitive guide provides invaluable business insights into every crucial aspect of this medication, addressing the vital points necessary to make business decisions.

Gain key critical insights for GIVLAARI:

  • United States patents
  • Expired United States patents
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Finished product suppliers
Pages

54
Product

GIVLAARI

Related products

ChemIntel360
Scroll to Top